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Background: Rotavirus antigenemia is a common phenomenon in children with rotavirus diarrhea, but information
is scarce on aspects of this phenomenon, such as genotype specificity, presence of intact viruses and correlation
between genomic RNA and antigen concentration. Such information may help in understanding rotavirus
pathogenesis and eventually be useful for diagnosis, treatment and prevention.
Methods and findings: Serum samples were collected from children who presented at hospitals with diarrhea.
Antigenemia was present in 162/250 (64.8%) samples from children with rotavirus diarrhea. No specific rotavirus
genotype was found to be associated with antigenemia. Rotavirus particles could not be found by electron
microscopy in concentrated serum from children with high levels of antigenemia. In passaged rotavirus suspension
a significant correlation (r = 0.9559; P = 0.0029) was found between antigen level and viral copy number, but no
significant correlation (r = 0.001480; P = 0.9919) was found between antigenemia level and viral copy number in
serum. When intact rotavirus was treated with benzonase endonuclease, genomic double-stranded (ds) RNA was
not degraded, but when sera of patients with antigenemia were treated with benzonase endonuclease, genomic
dsRNA was degraded, indicating genomic dsRNA was free in sera and not inside virus capsid protein.
Conclusions: Antigenemia is present in a significant number of patients with rotavirus diarrhea. Rotavirus viremia
was absent in the children with rotavirus diarrhea who participated in our study, and was not indicated by the
presence of antigenemia. The significance of circulating rotavirus antigen and genomic dsRNA in serum of patients
with diarrhea deserves further study.
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Globally, every year rotavirus infects 114 million children
and accounts for about 453,000 deaths mainly in develo-
ping countries [1,2]. RVA is a non-enveloped virus with a
triple-layered capsid containing 11 segments of double
stranded RNA genome. The nucleotide sequence of VP7
and VP4 characterize the G and P genotypes, respectively
[3]. These proteins are used in a binary classification
system, 27 G and 35 P types thus far has been identified
[4]. In general G1 through G4 and G9 are the most
common types causing human infection [5]. A variety of
diseases have been found to be associated with rotavirus
[6,7]. Detection of rotavirus antigen and/or RNA in the* Correspondence: ahmed@oita-u.ac.jp
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reproduction in any medium, provided the orcentral nervous system, heart, liver, testes, kidneys,
bladder, liver biopsy from infant with cholestatic disease,
respiratory secretions, lung cells, microvasculatures of
heart and serum of those patients have provided indirect
evidences of rotavirus or its components as a causative
agent [6]. How rotavirus or its components reach other
parts of the human body from the gastrointestinal tract is
not known. Saulsburry et al. first reported the presence of
rotavirus antigenemia in immunodeficient children with
chronic rotavirus diarrhea [8]. Early work suggested that
rotavirus antigenemia was the result of host immuno-
logical defects [8], but recent reports suggest that rotavirus
antigenemia is commonly observed in immunocompetent
children with rotavirus diarrhea.
Therefore, antigenemia could be at the center of the
pathogenesis of various extraintestinal infections with
rotavirus. However, several key characteristics of thisLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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associated with certain genotypes of rotavirus, whether
antigenemia consists of intact virus particles, or whether
there is any correlation between the concentrations of
virus particles and genomic RNA in serum. Information
on all these points will assist our understanding of the
pathogenesis of rotavirus infection and may open new
avenues for diagnosis, treatment and prevention of the
disease. The aim of the present study was therefore to
obtain further information about the characteristics of
rotavirus antigenemia.Results
Prevalence of rotavirus antigenemia in patients with and
without rotavirus diarrhea
A total of 250 serum samples were available from patients
with rotavirus diarrhea, and antigenemia was detected in
162 (64.8%) of these. Of the 250 serum samples, 169 were
from Bangladeshi children: in this group, antigenemia was
detected in 123 (72.8%) samples. Eighty-one samples were
from Turkish children, and antigenemia was detected in
39 (48.1%) of these samples. A total of 126 samples were
available from patients with diarrhea caused by agents
other than rotavirus: rotavirus antigenemia was detected
in 37 (29.4%) of these samples. Of these 126 serum sam-
ples, 7 were from Bangladeshi children, of which 5 (71.4%)Figure 1 Upper panel: Correlation between ELISA OD values of intact
panel: Correlation between antigenemia determined by ELISA and VP6 genshowed antigenemia and 119 were from Turkish children,
of which 32 (26.9%) showed antigenemia.
Electron microscopic observation of serum concentrates
from patients with antigenemia
Viral particles with characteristics suggestive of rotavirus
were not found in any of the samples. This result indicates
that intact rotavirus particle is absent in the serum of
patients with rotavirus antigenemia.
Correlation between viral copy number and ELISA
reactivity of cultured rotavirus and serum samples
Six samples containing different concentrations of rota-
virus strain SA11 were used to determine whether there is
a correlation between ELISA OD and the corresponding
viral genomic copy number determined by RT-qPCR
(Figure 1, Upper panel). The mean copy number and OD
values were 2.47 × 104 copies/μl (95% CI, 0 – 5.08× 104
copies/μl) and 1.045 (95% CI, 0.3784 – 1.711), respectively.
The correlation was significant: the Pearson r was 0.9559
(95% CI 0.6438 – 0.9953) and the P value was 0.0029. This
result indicates that when intact rotavirus is present there
is a significant correlation between OD and viral copy
number, i.e. the intensity of the OD corresponds to the
number of virus particles.
Serum samples from forty-nine patients were available
to determine the correlation between antigenemia levelvirus particles and VP6 gene copy numbers in RTqPCR. Lower
e copy number in serum.
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copy number determined by RT-qPCR. Except one sample
from a Turkish child all samples were rotavirus RNA
positive. The mean copy number and OD values were
1.24 × 108 copies/μl (95% CI, 0 – 2.89 × 108 copies/μl) and
0.5264 (0.3866 – 0.6663), respectively. The correlation was
not significant (Figure 1, Lower panel): the Spearman
r was 0.001480 (95% CI −0.2878 – 0.2905) and the P value
was 0.9919.
Genomic RNA protection assay by benzonase
endonuclease treatment
The results of the RT-PCR showed that extracted genomic
RNA of rotavirus strain SA11 was completely degraded by
benzonase nuclease, while untreated genomic RNA was in-
tact and generated a 479 bp product in RT-PCR (Figure 2).
When intact particles of rotavirus strain SA11 were treated
with benzonase endonuclease, genomic RNA was not
degraded and the VP6 gene could be amplified by RT-
PCR from RNA extracted from these particles. When
serum samples were treated with benzonase endonucle-
ase and RNA was extracted, the VP6 gene could not be
amplified by RT-PCR (Figure 3), while the VP6 gene
could be amplified from RNA extracted from untreated
sera. This assay provided evidence that naked RNA ra-
ther than intact virus particles were present in serum
during rotavirus antigenemia.
Distribution of VP7 genotypes in patients with and
without antigenemia
In Bangladeshi children, genotypes G1, G2, G4, G9, G12
and Gnt were found in 22 (18.5%), 31 (26.0%), 1 (1.8%), 8Figure 2 Genomic RNA protection assay by treatment with benzonas
gene amplification by RT-PCR after treating genomic RNA and intact virus
weight marker; genomic RNA of different concentrations (7.3 × 107, 9.0 × 10
6) and treated (lanes 3, 5 and 7) with 100 U of benzonase, different concen
untreated (lanes 8, 10 and 12) and treated (lanes 9, 11 and 13) with 100 U
(479 bp) are present in lanes 2, 4 and 6 and absent in lanes 3, 5 and 7, ind
endonuclease. Amplicons are present in lanes 8–13, indicating that genom
benzonase endonuclease.(6.7%), 11 (9.2%) and 46 (38.6%) children with antigene-
mia, and in 9 (18.4%), 19 (38.8%), 1 (2.0%), 0, 3 (6.1%) and
17 (43.7%) children without antigenemia, respectively. In
Turkish children, genotypes G1, G2, G3, G4, G9, and Gnt
were found in 28 (71.8%), 0, 1 (2.6%), 0, 5 (12.8%) and 5
(12.8%) children with antigenemia, and in 20 (51.2%), 1
(2.6%), 1 (2.6%), 1 (2.6%), 5 (12.8%) and 11 (28.2%) children
without antigenemia, respectively. A χ2 test was done to
determine whether genotype distribution differed signifi-
cantly between children with and without antigenemia. In
Bangladeshi children, the following results were obtained
for genotypes G1, G2 and Gnt: χ2 = 1.665, degrees of free-
dom (df) = 2 and P = 0.4350 (Figure 4). In Turkish
children, the following results were obtained for genotypes
G1, G9 and Gnt: χ2 = 3.532, df = 2 and P = 0.1710
(Figure 4). There was no significant difference in genotype
distribution between children with and without antigene-
mia in either group.
Discussion
The frequency of antigenemia in children with rotavirus
diarrhea that was determined in the present study is within
the range observed in other studies [9-13]. Although the
prevalence of rotavirus diarrhea in Bangladesh and Turkey
is similar [14,15], it is difficult to say why in Bangladeshi
children the frequency of antigenemia was higher than
Turkish children. Detection of rotavirus antigenemia is
influenced by several factors such as increased acute-phase
serum immunoglobulin G antibody titer [11], days after
onset of diarrhea [11,12] and stool viral antigen levels [11].
Although in this study the frequency of antigenemia found
in the rotavirus-negative diarrhea patients seems to be highe endonuclease. Agarose gel electrophoresis shows results of VP6
particles with benzonase endonuclease. Lane 1, 100 bp molecular
5 and 8.5 × 103) of rotavirus SA11 strain were untreated (lanes 2, 4 and
trations (7.3 × 107, 9.0 × 105 and 8.5 × 103) of rotavirus SA11 strain were
of benzonase, and lane 14 contains negative control. Amplicons of VP6
icating that in these lanes, genomic RNA is degraded by benzonase
ic RNA is protected when intact rotavirus particles are treated with
Figure 3 Genomic RNA protection assay performed by treating sera of four antigenemia patients with benzonase endonuclease. The
photo of agarose gel electrophoresis shows an amplicon of the VP6 gene. Lane 1, contains a 100 bp molecular weight marker. In lanes 2, 5, 8
and 11, VP6 amplicons (479 bp) are present in RNA extracted from sera but not treated with benzonase endonuclease. In lanes 3, 6, 9 and 12,
VP6 amplicons are absent in RNA extracted from sera then treated with benzonase endonuclease. In lanes 4, 7, 10 and 13, VP6 amplicons are
absent in RNA extracted from sera that had been treated with benzonase endonuclease; and lane 14 contains negative control. The absence of
amplicons of VP6 gene in sera treated with benzonase indicates that intact rotavirus particles were absent in sera of patients with antigenemia,
and therefore RNA was degraded.
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cult as studies on rotavirus antigenemia in children with
rotavirus-negative diarrhea are scarce. The high frequency
found in this study may reflect factors such as differences
in study population, the high prevalence of rotavirus diar-
rhea in the study children or sensitivity of the methodFigure 4 Distribution of rotavirus genotypes in Bangladeshi (upper p
without antigenemia.utilized to detect antigenemia. It is possible that the study
children had had a rotavirus infection and recovered before
collection of serum but continued to have diarrhea for
some reason, because although antigen levels peak 1–3 days
after the onset of symptoms and the serum of some
children remains positive beyond 1 week, a decline inanel) and Turkish children (lower panel) with and
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has been observed [11]. Rotavirus antigenemia has even
been found in children with no gastroenteritis [10]: a recent
study revealed that 18.5% of the healthy children have rota-
virus in their stool [17]. Therefore, detecting several cases
of rotavirus antigenemia in children without rotavirus
diarrhea is not uncommon. In the present study the total
number of such samples from Bangladeshi children was
small and therefore the high positive antigenemia rate in
those children can be almost ignored. Reviewing the serum
sample collection period of rotavirus negative Turkish
children showed that the majority of the antigenemia
positive samples were from the rotavirus season which
might be responsible for high frequency of antigenemia in
this group of children.
In the case of rotavirus grown in the MA104 cell line,
there may only be one infectious virus particle in 46,000
virus particles [18]. If there are a low number of infectious
virus particles during rotavirus antigenemia, then serum
culture will be unsuccessful. In the present study, two dif-
ferent approaches were undertaken to determine whether
intact rotavirus is present in the serum of patients with
antigenemia. In one approach, serum samples with high
levels of antigenemia were observed under the electron
microscope to obtain direct evidence of the presence of
intact rotavirus particles. In the other approach, we
predicted that the presence of intact rotavirus parti-
cles in serum samples of patients with antigenemia
will protect genomic RNA from endonuclease and
there will be a correlation between serum antigen
level and viral copy number. Benzonase endonuclease
was used for the endonuclease protection assay. Ben-
zonase endonuclease degrades both DNA and RNA,
whether single-stranded, double-stranded, linear, circu-
lar or supercoiled (http://wolfson.huji.ac.il/purification/
PDF/DNA_Removal/NOVOGEN_Benzonase.pdf).
The use of electron microscopy in serological identifica-
tion of viruses is an established technique. Two major
limitations of electron microscopic detection of extracellu-
lar viruses are the requirement for a relatively high concen-
tration of virus (105 to 107/ml, depending on size) and the
presence of background materials (such as serum proteins)
that may mask the virus particles [19]. The concentrations
of virus in our samples were more than adequate to be
observed under the electron microscope. The ELISA OD
values of the serum samples used for electron microscopy
correspond to more than 5 × 105 rotavirus particles/ml. In
addition, the samples were concentrated 20× concentrated
by ultracentrifugation, which should make the concentra-
tion of any viral particles present in the serum at least
1 × 107 rotavirus particles/ml. Had there been viremia
during rotavirus diarrhea, these serum samples would have
contained enough rotavirus particles to be visualized by
electron microscopy. Our experience with culturedrotavirus particles indicates that the characteristic features
of rotavirus particles are unlikely to be missed by electron
microscopy, even in the presence of background materials,
because they cannot mask all the virus particles.
In this study, we provided evidence that the ELISA OD
of intact virus correlates significantly with the copy num-
ber. However, serum ELISA OD values did not correlate
with serum virus copy numbers, which suggested that
intact virus particles are not present during rotavirus anti-
genemia. The absence of intact virus particles in the serum
of patients with antigenemia was confirmed by showing
degradation of viral RNA in serum by benzonase endo-
nuclease treatment. In an intact virus particle, the protein
coat protects the genome from degradation by nucleases,
therefore absence of this protection during treatment with
benzonase endonuclease demonstrated that viremia was
absent during rotavirus diarrhea.
There is only one study that showed the presence of
viremia in all of the antigenemia-positive and 22% of the
antigenemia-negative children tested by culturing their
sera [10]. Virus culture may be more sensitive than elec-
tron microscopy, but PCR after benzonase treatment of
serum as used in this study is more sensitive than virus
culture. The present study provides evidence that free
viremia is absent in patients with rotavirus antigenemia,
possibly indicating a role for differences in population
genetics in causing viremia.
Previous results confirmed that rotavirus G genotypes
of the fecal and serum samples from the same patient
were identical [20]. Therefore, we used the genotypes
found in stool as representative of the genotypes causing
antigenemia in the corresponding serum samples. We
found no significant differences in genotype distribution
between antigenemia positive and negative patients,
indicating that it is unlikely that particular genotypes are
capable of causing antigenemia. Similar results were
found by Fujita et al. [20], which together with our data
suggests that there is no particular genotype of rotavirus
that is more likely to cause antigenemia.
In conclusion, there was no specific rotavirus genotype
associated with antigenemia, and viremia was absent in
children with rotavirus antigenemia. Further study is
needed to verify whether there is cell-associated viremia
in children with rotavirus antigenemia.
Materials and methods
Ethics review of the proposal and consent
The research proposal was approved by the ethics review
board of the Faculty of Medicine, Gazi University and
the ethics committee of the Institute of Child and
Mother Health (ICMH). The verbal consent of the
child’s guardian was obtained prior to sample collection.
Since a fraction was obtained from samples sent to the
laboratory of routine diagnostic purposes therefore
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not required by the ethics review boards.
Collection of specimens
Children enrolled in this study were less than 5 years old.
This is part of studies on rotavirus diarrhea previously
carried out in Turkey and Bangladesh [14,15]. Between
September 2004 and December 2005, samples were
collected from patients who attended at Gazi University
Hospital and the Ministry of Health Ankara Educational
and Research Hospital in Ankara, Turkey with watery
diarrhea. During July 2005-June 2006, samples were
collected from children who attended at the affiliated
hospital of ICMH, Matuail, Dhaka, Bangladesh with
watery diarrhea. A case of diarrhea was defined as passing
looser than normal stool three or more times, during a
24 hour period. One stool and one serum sample were
collected from each patient and stored at −80°C until use.
Detection of rotavirus in stool
Rotavirus antigen was detected from a 10% stool dilution
in phosphate-buffered saline by enzyme immunoassay
(Rotaclone, Meridian Diagnostics Inc., Cincinnati, Ohio,
USA), according to the manufacturer’s instructions.
Detection of rotavirus antigenemia
Rotavirus antigenemia was detected by a previously pub-
lished method [21]. A twofold dilution of serum was made
with phosphate-buffered saline (pH 7.2), and 100 μl of this
was used for rotavirus antigen detection by Rotaclone.
Absorbance of 0.15 or more was used as the criterion for
positive reactions.
Observation of serum concentrates under electron
microscopy
Four serum samples with relatively high optical density
(OD) were selected during the detection of antigenemia for
observation by electron microscopy. Samples 184 and 109
(OD values 2.333 and 1.874) were obtained from two
Bangladeshi children with rotavirus diarrhea and antigene-
mia. Samples AHP20 and GUP30 (OD values 0.409 and
0.373) were obtained from two Turkish children with rota-
virus diarrhea and antigenemia. Serum was concentrated
by ultracentrifugation: 400 μl of serum was mixed with an
equal volume of 0.9% NaCl solution and laid on a 30%
sucrose cushion. Using a Beckman 100.2 rotor, samples
were centrifuged at 50,000 rpm for 1 hour at 4°C. The
pellet was resuspended in 20 μl 0.9% NaCl solution, and
5 μl of this was applied to a carbon-coated copper grid and
then stained with 2% uranyl acetate for 30 sec. The excess
of fluid was removed by a piece of filter paper. Specimens
were observed under a JEM 100C electron microscope
(JEOL Ltd., Tokyo, Japan) operated at 80 kV. The gridswere observed blinded at a magnification of × 36,000 or
greater [22].
Correlation between ELISA OD and copy number of
cultured virus
To determine whether there is a correlation between
ELISA OD and virus genome copy number when intact
virus particles are present in a fluid, cultured rotavirus
strain SA11 suspended in phosphate-buffered saline
(PBS) was serially diluted twofold in PBS, and then
ELISA OD was determined as described above and the
copy number in each diluted sample was determined as
described below. The correlation between ELISA OD
and copy number was determined as described in the
statistical analysis section.
Determination of virus copy number in serum
Rotavirus copy number was determined by reverse tran-
scription quantitative polymerase chain reaction (RT-qPCR)
[23]. Nucleic acid was extracted from 140 μl of serum using
the QIAamp Viral RNA Mini kit (Qiagen Co. Ltd., Tokyo,
Japan). RT-qPCR with VP6-specific primers was carried out
using the QuantiTect SYBR Green RT-PCR kit (Qiagen)
and a LightCyclerTM 480 (Roche, Mannheim, Germany)
real-time PCR thermal cycler. The primers VP6- F (sense)
(5′ −GACGGVGCRACTACATGGT− 3′) (nucleotides [nt]
747–766) and VP6-R (antisense) (5′ −GTCCAATTCATNC
CTGGTGG − 3′) (nt 1126–1106) amplified a 379-bp region
(nt 747–1126) of the VP6 gene [24]. The genomic dsRNA
was extracted from cultured rotavirus strain SA11 by the
phenol− chloroform − isoamyl alcohol method and run on
a 0.8% agarose gel. Segment 6 was cut out, and then dsRNA
was extracted and purified by QIAquick Gel Extraction
kit (Qiagen) according to the manufacturer’s instructions.
A standard curve was generated by amplifying a known
amount of dsRNA [25]. One copy of rotavirus equals
1.29 × 10−12 μg of segment 6 dsRNA. A serial 10-fold dilu-
tion of extracted and purified VP6 was used for calibration
using the LightCyclerTM 480 software and a reference gene
for normalization between PCR runs. The crossing point,
defined as the PCR cycle at which the amplification signal
intersects the log linear region, was used as a direct correl-
ate of the amount of rotavirus RNA present in the serum.
Each sample was measured three times and the average
was taken to calculate the copy number.
Genomic RNA protection assay by benzonase
endonuclease treatment
To determine whether antigenemia consists of intact rota-
virus particles, sera were treated with benzonase endo-
nuclease (Novagen EMD Chemicals, San Diego, CA,
USA), and then VP6-specific RT-PCR was performed to
determine the presence or absence of genomic RNA. In
the presence of intact virus particles, the genomic RNA
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will be amplified by RT-PCR. However, if naked RNA is
present, it will be degraded and RT-PCR will show a nega-
tive result. To determine the optimum conditions for this
assay, different amounts (7.3 × 107, 9.0 × 105 and 8.5 × 103)
of rotavirus SA11 strain and corresponding genomic RNA
in distilled water were treated with 100 U of benzonase
for 22 hours at 37°C according to the manufacturer’s
instructions. The reaction was stopped by adding EDTA at
a final concentration of 2 mM to inactivate by the benzo-
nase. Specimens handled similarly without benzonase
treatment were used as a control. Nucleic acid was
extracted using a QIAamp viral RNA minikit according to
the manufacturer’s instructions and subjected to RT-PCR
for the detection of the VP6 gene using primers and me-
thods described elsewhere [14,24].
Distribution of genotypes in patients with and without
antigenemia
To determine the effects of rotavirus genotype distribution
on antigenemia, the genotype distribution of rotavirus
found in stool was compared in patients with and without
antigenemia. Genotypes were determined by RT-PCR as
described in our previous studies [14,15].
Statistical analysis
The Mann–Whitney test and Spearman rank correlation,
appropriate for experimental data that display a non-
Gaussian distribution [26], were used to calculate two-
tailed P values. The Pearson correlation was used for
experimental data that displayed a Gaussian distribution.
The χ2 test was used to determine whether genotype distri-
bution differed between patients with and without antige-
nemia. All statistical analyses were performed using Prism
5 software (GraphPad Software Inc., La Jolla, CA, USA).
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